Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About March 15, 2022
February 14, 2022 at 08:37 am EST
Share
Pharma-Bio Serv, Inc.'s Board of Directors approved a special dividend of $0.075 per share to shareholders. The dividend is payable on or about March 15, 2022 to shareholders of record at the close of business on February 25, 2022.
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
PHARMA-BIO SERV, INC. 
